A rigorous 24-month longitudinal study in Indonesia compared the immunogenicity of fractional versus standard dose COVID-19 vaccine boosters in healthy adults. Published in Nature Communications, the study provides one of the most comprehensive datasets on vaccine-induced immunity durability, informing optimized booster dosing strategies for sustained protection. These insights are vital to refining public health guidelines amid evolving viral variants and vaccination programs.